Tuesday, February 20, 2007

Leuprolide for Alzheimer's

One of the clinical trials I was involved in, the ALADDIN study, was terminated abruptly last year because of financial issues from the sponsoring pharmaceutical company. The study had a promising start - Memryte, which is basically an implantable form of leuprolide, has shown to be effective for Alzheimer's treatment in Phase II trials. Some of the patients that I had been following showed improved cognition as well. The theory behind leuprolide, which involves LH production and cell division, is very interesting but is beyond the scope of this entry.

I am glad to see that they are still working on reviving the study. Alzheimer's is a hot research field right now because of its lucrativeness but to the end, the general public will benefit so let's keep them running!

No comments: